T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 151–200 of 374 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00069238	Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas	completed	Phase 2	31	National Cancer Institute (NCI)NIH	1	Feb 24, 2022	clinicaltrials
NCT04955340	A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat	completed	Phase 1	5	4SC AGINDUSTRY	1	Feb 18, 2022	clinicaltrials
NCT01186640